Mariko Oishi

The status of diabetes control and antidiabetic drug therapy in Japan—A cross-sectional survey of 17,000 patients with diabetes mellitus (JDDM 1)

Masashi Kobayashi, Katsuya Yamazaki, Koichi Hirao et al. · Diabetes Research and Clinical Practice · 2006 · 148 citations

Diabetes Management, Diabetes Epidemiology, Health Policy +9

The C42R Mutation in the Kir6.2 (KCNJ11) Gene as a Cause of Transient Neonatal Diabetes, Childhood Diabetes, or Later-Onset, Apparently Type 2 Diabetes Mellitus

Tohru Yorifuji, Kazuaki Nagashima, Keiji Kurokawa et al. · The Journal of Clinical Endocrinology & Metabolism · 2005 · 122 citations · Full text

Cardio-ankle vascular index predicts for the incidence of cardiovascular events in obese patients: A multicenter prospective cohort study (Japan Obesity and Metabolic Syndrome Study: JOMS)

Noriko Satoh‐Asahara, Kazuhiko Kotani, Hajime Yamakage et al. · Atherosclerosis · 2015 · 91 citations

Obesity, Metabolic Syndrome, Japan Obesity +11

Changes in oral antidiabetic prescriptions and improved glycemic control during the years 2002–2011 in <scp>J</scp>apan (<scp>JDDM</scp>32)

Mariko Oishi, Katsuya Yamazaki, FUMINOBU OKUGUCHI et al. · Journal of Diabetes Investigation · 2013 · 90 citations · Full text

Large-scale survey of rates of achieving targets for blood glucose, blood pressure, and lipids and prevalence of complications in type 2 diabetes (JDDM 40)

Hiroki Yokoyama, Mariko Oishi, Hiroshi Takamura et al. · BMJ Open Diabetes Research & Care · 2016 · 82 citations · Full text